Christopher M. Acker

2.7k citations

26 papers · 2.1k indexed · h-index 18

Impact in

Neurology top 1%
- Neuroinflammation and Neurodegeneration Mechanisms
- Traumatic Brain Injury and Neurovascular Disturbances
Physiology top 2%
- Alzheimer's disease research and treatments

Papers in ⓘ

Physiology 15
- Alzheimer's disease research and treatments 13
Molecular Biology 12
- Glycosylation and Glycoproteins Research 3
- Protein Kinase Regulation and GTPase Signaling 3

Co-authors: Peter Davies (16 shared papers)Karen Duff (3 shared papers)Peter Davies (4 shared papers)Patrick R. Hof (1 shared paper)Cathy Andorfer (1 shared paper)Yvonne Kress (1 shared paper)Cristina d’Abramo (9 shared papers)Manuela Polydoro (1 shared paper)
Journals: Journal of Alzheimer s Disease (3 papers)PLoS ONE (3 papers)Alzheimer s & Dementia (2 papers)Blood (2 papers)Journal of Neuroscience (2 papers)
Partner nations: United States India Switzerland

In The Last Decade

Christopher M. Acker

26 papers receiving 2.0k citations

Peers

Countries citing papers authored by Christopher M. Acker

Since Specialization

Citations

This map shows the geographic impact of Christopher M. Acker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Acker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Acker more than expected).

Fields of papers citing papers by Christopher M. Acker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. Acker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Acker. The network helps show where Christopher M. Acker may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher M. Acker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher M. Acker Line = papers co-authored together Christopher M. Acker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Small Misfolded Tau Species Are Internalized via Bulk Endocytosis and Anterogradely and Retrogradely Transported in Neurons Journal of Biological Chemistry ·Jessica Wu, Mathieu Herman, Li Liu, Sabrina Simoes, Christopher M. Acker, Helen Y. Figueroa, Joshua Steinberg, Martin Margittai, Rakez Kayed, Chiara Zurzolo, Gilbert Di Paolo, Karen Duff	2012	408
2	Cell-Cycle Reentry and Cell Death in Transgenic Mice Expressing Nonmutant Human Tau Isoforms Journal of Neuroscience ·Cathy Andorfer, Christopher M. Acker, Yvonne Kress, Patrick R. Hof, Karen Duff, Peter Davies	2005	396
3	Chronic neuropathological and neurobehavioral changes in a repetitive mild traumatic brain injury model Annals of Neurology ·Benoit Mouzon, Corbin Bachmeier, Austin Ferro, J. Villegas-del Ojo, Gogce Crynen, Christopher M. Acker, Peter Davies, Michael Mullan, William Stewart, Fiona Crawford	2013	263
4	Age-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau Pathology Journal of Neuroscience ·Manuela Polydoro, Christopher M. Acker, Karen Duff, Pablo E. Castillo, Peter Davies	2009	256
5	Tau Passive Immunotherapy in Mutant P301L Mice: Antibody Affinity versus Specificity PLoS ONE ·Cristina d’Abramo, Christopher M. Acker, Heidy Jimenez, Peter Davies	2013	118
6	c-Abl in Neurodegenerative Disease Journal of Molecular Neuroscience ·Sarah D. Schlatterer, Christopher M. Acker, Peter Davies	2011	107
7	Lifelong behavioral and neuropathological consequences of repetitive mild traumatic brain injury Annals of Clinical and Translational Neurology ·Benoit Mouzon, Corbin Bachmeier, Joseph Ojo, Christopher M. Acker, Scott Ferguson, Daniel Paris, Ghania Ait‐Ghezala, Gogce Crynen, Peter Davies, Michael Mullan, William Stewart, Fiona Crawford	2017	89
8	Tau Phosphorylated at Tyrosine 394 is Found in Alzheimer's Disease Tangles and can be a Product of the Abl-Related Kinase, Arg Journal of Alzheimer s Disease ·Matthew Tremblay, Christopher M. Acker, Peter Davies	2010	85
9	Neuronal c-Abl Overexpression Leads to Neuronal Loss and Neuroinflammation in the Mouse Forebrain Journal of Alzheimer s Disease ·Sarah D. Schlatterer, Matthew Tremblay, Christopher M. Acker, Peter Davies	2011	55
10	Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models Neurobiology of Aging ·Christopher M. Acker, Stefanie Forest, Ray Zinkowski, Peter Davies, Cristina d’Abramo	2012	48
11	Passive Immunization in JNPL3 Transgenic Mice Using an Array of Phospho-Tau Specific Antibodies PLoS ONE ·Cristina d’Abramo, Christopher M. Acker, Heidy Jimenez, Peter Davies	2015	37
12	Chronic White Matter Degeneration, but No Tau Pathology at One-Year Post-Repetitive Mild Traumatic Brain Injury in a Tau Transgenic Model Journal of Neurotrauma ·Benoit Mouzon, Corbin Bachmeier, Joseph Ojo, Christopher M. Acker, Scott Ferguson, Gogce Crynen, Peter Davies, Michael Mullan, William Stewart, Fiona Crawford	2018	37
13	Autologous cryopreserved leukapheresis cellular material for chimeric antigen receptor–T cell manufacture Cytotherapy ·Seshu Tyagarajan, David A. Schmitt, Christopher M. Acker, Erik Rutjens	2019	31
14	Mice Devoid of Tau Have Increased Susceptibility to Neuronal Damage in Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis Journal of Neuropathology & Experimental Neurology ·Jason G. Weinger, Peter Davies, Christopher M. Acker, Celia F. Brosnan, Vladislav Tsiperson, Ashrei Bayewitz, Bridget Shafit‐Zagardo	2012	26
15	Transgenic Expression of the Amyloid-β Precursor Protein-Intracellular Domain Does Not Induce Alzheimer's Disease–Like Traits In Vivo PLoS ONE ·Luca Giliberto, Cristina d’Abramo, Christopher M. Acker, Peter Davies, Luciano D'adamio	2010	21
16	Pathogenic tau species drive a psychosis-like phenotype in a mouse model of Alzheimer's disease Behavioural Brain Research ·Jeremy Koppel, Heidy Jimenez, Miriam Azose, Cristina d’Abramo, Christopher M. Acker, Justin J. Buthorn, Blaine Greenwald, Jada Lewis, Martin Lesser, Z. Liu, Peter Davies	2014	20
17	Detecting tau in serum of transgenic animal models after tau immunotherapy treatment Neurobiology of Aging ·Cristina d’Abramo, Christopher M. Acker, Joel B. Schachter, Giuseppe Terracina, Xiaohai Wang, Stefanie Forest, Peter Davies	2015	17
18	Methods for Measuring Tau Pathology in Transgenic Mouse Models Journal of Alzheimer s Disease ·Stefanie Forest, Christopher M. Acker, Cristina d’Abramo, Peter Davies	2012	17
19	Neuronal c-Abl activation leads to induction of cell cycle and interferon signaling pathways Journal of Neuroinflammation ·Sarah D. Schlatterer, Hyeon-Sook Suh, Concepcion Conejero‐Goldberg, Shufen Chen, Christopher M. Acker, Sunhee C. Lee, Peter Davies	2012	13
20	A Modification-Specific Peptide-Based immunization Approach Using CRM197 Carrier Protein: Development of a Selective Vaccine Against Pyroglutamate Aβ Peptides Molecular Medicine ·Valérie Vingtdeux, Haitian Zhao, Pallavi Chandakkar, Christopher M. Acker, Peter Davies, Philippe Marambaud	2016	9

About Christopher M. Acker

Christopher M. Acker is a scholar working on Physiology, Molecular Biology, Cellular and Molecular Neuroscience, Neurology and Oncology, having authored 26 papers that have together received 2.1k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (13 papers), Neuroscience and Neuropharmacology Research (7 papers), CAR-T cell therapy research (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Glycosylation and Glycoproteins Research (3 papers), Traumatic Brain Injury Research (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). The work is most often cited by research in Neurology (576 citations), Physiology (1.3k citations), Neurology (549 citations), Cellular and Molecular Neuroscience (635 citations) and Biological Psychiatry (61 citations). Christopher M. Acker has collaborated with scholars based in United States, India and Switzerland. Frequent co-authors include Peter Davies, Karen Duff, Peter Davies, Patrick R. Hof, Cathy Andorfer, Yvonne Kress, Cristina d’Abramo, Manuela Polydoro, Sarah D. Schlatterer and Pablo E. Castillo. Their work appears in journals such as Journal of Alzheimer s Disease, PLoS ONE, Alzheimer s & Dementia, Blood and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact